nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Icatibant—BDKRB2—hypertension	0.0103	1	CrCbGaD
Goserelin—GNRHR—Signaling Pathways—ADM—hypertension	7.27e-05	0.000198	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KL—hypertension	7.2e-05	0.000196	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH2—hypertension	7.2e-05	0.000196	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNB3—hypertension	7.17e-05	0.000195	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLP1R—hypertension	7.09e-05	0.000193	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CYBB—hypertension	7.09e-05	0.000193	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TACR1—hypertension	7.09e-05	0.000193	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—hypertension	7.08e-05	0.000193	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AVP—hypertension	7.07e-05	0.000192	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NGFR—hypertension	7.07e-05	0.000192	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ITGAV—hypertension	7.07e-05	0.000192	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hypertension	7.06e-05	0.000192	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KNG1—hypertension	7.04e-05	0.000191	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADCY5—hypertension	7.04e-05	0.000191	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—POMC—hypertension	7.02e-05	0.000191	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGTR1—hypertension	7e-05	0.00019	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRL—hypertension	7e-05	0.00019	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PRKCG—hypertension	6.99e-05	0.00019	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNAS—hypertension	6.98e-05	0.00019	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRH3—hypertension	6.97e-05	0.00019	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PRKCA—hypertension	6.94e-05	0.000189	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STK11—hypertension	6.9e-05	0.000188	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HDAC1—hypertension	6.9e-05	0.000188	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL2—hypertension	6.87e-05	0.000187	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL10—hypertension	6.84e-05	0.000186	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLG—hypertension	6.82e-05	0.000185	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—RHOA—hypertension	6.81e-05	0.000185	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT2—hypertension	6.75e-05	0.000183	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3R1—hypertension	6.74e-05	0.000183	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EDN1—hypertension	6.73e-05	0.000183	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL5—hypertension	6.67e-05	0.000181	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRB2—hypertension	6.64e-05	0.000181	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PRKCD—hypertension	6.62e-05	0.00018	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR5—hypertension	6.62e-05	0.00018	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCE—hypertension	6.56e-05	0.000178	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NCF2—hypertension	6.48e-05	0.000176	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HTR2A—hypertension	6.48e-05	0.000176	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFA—hypertension	6.48e-05	0.000176	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VAV3—hypertension	6.48e-05	0.000176	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—C3—hypertension	6.47e-05	0.000176	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADCY5—hypertension	6.39e-05	0.000174	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFBR2—hypertension	6.39e-05	0.000174	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCG—hypertension	6.35e-05	0.000173	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNB3—hypertension	6.33e-05	0.000172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NPY—hypertension	6.32e-05	0.000172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VWF—hypertension	6.32e-05	0.000172	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCA—hypertension	6.3e-05	0.000171	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AVP—hypertension	6.24e-05	0.00017	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RHOA—hypertension	6.19e-05	0.000168	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNAS—hypertension	6.16e-05	0.000167	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGT—hypertension	6.15e-05	0.000167	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3R1—hypertension	6.12e-05	0.000166	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—OXT—hypertension	6.1e-05	0.000166	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR1B—hypertension	6.1e-05	0.000166	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL2—hypertension	6.1e-05	0.000166	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGTR2—hypertension	6.1e-05	0.000166	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOB—hypertension	6.03e-05	0.000164	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFBR1—hypertension	6.03e-05	0.000164	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2R—hypertension	6.03e-05	0.000164	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR5—hypertension	6.01e-05	0.000163	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCD—hypertension	6.01e-05	0.000163	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTK2—hypertension	6.01e-05	0.000163	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—hypertension	5.98e-05	0.000163	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EDN1—hypertension	5.94e-05	0.000161	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL5—hypertension	5.89e-05	0.00016	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR2A—hypertension	5.88e-05	0.00016	CbGpPWpGaD
Goserelin—Abdominal pain—Irbesartan—hypertension	5.88e-05	9.46e-05	CcSEcCtD
Goserelin—Body temperature increased—Irbesartan—hypertension	5.88e-05	9.46e-05	CcSEcCtD
Goserelin—Thrombocytopenia—Ramipril—hypertension	5.88e-05	9.45e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—C3—hypertension	5.88e-05	0.00016	CbGpPWpGaD
Goserelin—Oedema—Timolol—hypertension	5.87e-05	9.44e-05	CcSEcCtD
Goserelin—Anaphylactic shock—Timolol—hypertension	5.87e-05	9.44e-05	CcSEcCtD
Goserelin—Rash—Verapamil—hypertension	5.86e-05	9.43e-05	CcSEcCtD
Goserelin—Urticaria—Hydrochlorothiazide—hypertension	5.86e-05	9.43e-05	CcSEcCtD
Goserelin—Tachycardia—Ramipril—hypertension	5.86e-05	9.42e-05	CcSEcCtD
Goserelin—Dermatitis—Verapamil—hypertension	5.86e-05	9.42e-05	CcSEcCtD
Goserelin—Headache—Nifedipine—hypertension	5.85e-05	9.41e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—EDNRB—hypertension	5.84e-05	0.000159	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NCF1—hypertension	5.84e-05	0.000159	CbGpPWpGaD
Goserelin—Pruritus—Clonidine—hypertension	5.84e-05	9.39e-05	CcSEcCtD
Goserelin—Body temperature increased—Hydrochlorothiazide—hypertension	5.83e-05	9.38e-05	CcSEcCtD
Goserelin—Abdominal pain—Hydrochlorothiazide—hypertension	5.83e-05	9.38e-05	CcSEcCtD
Goserelin—Skin disorder—Ramipril—hypertension	5.83e-05	9.38e-05	CcSEcCtD
Goserelin—Infection—Timolol—hypertension	5.83e-05	9.38e-05	CcSEcCtD
Goserelin—Headache—Verapamil—hypertension	5.82e-05	9.37e-05	CcSEcCtD
Goserelin—Hypersensitivity—Telmisartan—hypertension	5.82e-05	9.37e-05	CcSEcCtD
Goserelin—Cough—Lisinopril—hypertension	5.82e-05	9.36e-05	CcSEcCtD
Goserelin—Nausea—Indapamide—hypertension	5.81e-05	9.34e-05	CcSEcCtD
Goserelin—Nausea—Diltiazem—hypertension	5.81e-05	9.34e-05	CcSEcCtD
Goserelin—Hyperhidrosis—Ramipril—hypertension	5.8e-05	9.33e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—TAC1—hypertension	5.78e-05	0.000157	CbGpPWpGaD
Goserelin—Asthenia—Trandolapril—hypertension	5.77e-05	9.28e-05	CcSEcCtD
Goserelin—Shock—Timolol—hypertension	5.77e-05	9.28e-05	CcSEcCtD
Goserelin—Feeling abnormal—Losartan—hypertension	5.77e-05	9.28e-05	CcSEcCtD
Goserelin—Urticaria—Furosemide—hypertension	5.76e-05	9.27e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—LPL—hypertension	5.76e-05	0.000157	CbGpPWpGaD
Goserelin—Nervous system disorder—Timolol—hypertension	5.75e-05	9.25e-05	CcSEcCtD
Goserelin—Nausea—Carvedilol—hypertension	5.75e-05	9.25e-05	CcSEcCtD
Goserelin—Asthenia—Enalapril—hypertension	5.75e-05	9.25e-05	CcSEcCtD
Goserelin—Body temperature increased—Furosemide—hypertension	5.74e-05	9.22e-05	CcSEcCtD
Goserelin—Abdominal pain—Furosemide—hypertension	5.74e-05	9.22e-05	CcSEcCtD
Goserelin—Gastrointestinal pain—Losartan—hypertension	5.72e-05	9.21e-05	CcSEcCtD
Goserelin—Dizziness—Valsartan—hypertension	5.72e-05	9.2e-05	CcSEcCtD
Goserelin—Anorexia—Ramipril—hypertension	5.72e-05	9.2e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—H2AFX—hypertension	5.72e-05	0.000155	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFRB—hypertension	5.71e-05	0.000155	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RPS6KB1—hypertension	5.71e-05	0.000155	CbGpPWpGaD
Goserelin—Urticaria—Betaxolol—hypertension	5.71e-05	9.18e-05	CcSEcCtD
Goserelin—Skin disorder—Timolol—hypertension	5.7e-05	9.17e-05	CcSEcCtD
Goserelin—Dizziness—Olmesartan—hypertension	5.7e-05	9.16e-05	CcSEcCtD
Goserelin—Pruritus—Trandolapril—hypertension	5.69e-05	9.16e-05	CcSEcCtD
Goserelin—Nausea—Doxazosin—hypertension	5.69e-05	9.15e-05	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PRKCB—hypertension	5.68e-05	0.000154	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—F2—hypertension	5.68e-05	0.000154	CbGpPWpGaD
Goserelin—Chest pain—Lisinopril—hypertension	5.68e-05	9.13e-05	CcSEcCtD
Goserelin—Arthralgia—Lisinopril—hypertension	5.68e-05	9.13e-05	CcSEcCtD
Goserelin—Myalgia—Lisinopril—hypertension	5.68e-05	9.13e-05	CcSEcCtD
Goserelin—Body temperature increased—Betaxolol—hypertension	5.68e-05	9.13e-05	CcSEcCtD
Goserelin—Hyperhidrosis—Timolol—hypertension	5.67e-05	9.12e-05	CcSEcCtD
Goserelin—Asthenia—Telmisartan—hypertension	5.67e-05	9.12e-05	CcSEcCtD
Goserelin—Pruritus—Enalapril—hypertension	5.67e-05	9.12e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ANXA1—hypertension	5.67e-05	0.000154	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCR3—hypertension	5.67e-05	0.000154	CbGpPWpGaD
Goserelin—Anxiety—Lisinopril—hypertension	5.66e-05	9.1e-05	CcSEcCtD
Goserelin—Diarrhoea—Clonidine—hypertension	5.64e-05	9.08e-05	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	5.64e-05	9.07e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADCY5—hypertension	5.64e-05	0.000153	CbGpPWpGaD
Goserelin—Nausea—Fosinopril—hypertension	5.62e-05	9.04e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—IKBKB—hypertension	5.61e-05	0.000153	CbGpPWpGaD
Goserelin—Discomfort—Lisinopril—hypertension	5.61e-05	9.02e-05	CcSEcCtD
Goserelin—Hypotension—Ramipril—hypertension	5.61e-05	9.02e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PRKCG—hypertension	5.6e-05	0.000152	CbGpPWpGaD
Goserelin—Anorexia—Timolol—hypertension	5.59e-05	9e-05	CcSEcCtD
Goserelin—Pruritus—Telmisartan—hypertension	5.59e-05	8.99e-05	CcSEcCtD
Goserelin—Nausea—Eplerenone—hypertension	5.59e-05	8.99e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AGT—hypertension	5.58e-05	0.000152	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ITGB3—hypertension	5.56e-05	0.000151	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCA—hypertension	5.56e-05	0.000151	CbGpPWpGaD
Goserelin—Urticaria—Losartan—hypertension	5.56e-05	8.94e-05	CcSEcCtD
Goserelin—Dry mouth—Lisinopril—hypertension	5.55e-05	8.93e-05	CcSEcCtD
Goserelin—Nausea—Nifedipine—hypertension	5.55e-05	8.92e-05	CcSEcCtD
Goserelin—Abdominal pain—Losartan—hypertension	5.53e-05	8.9e-05	CcSEcCtD
Goserelin—Body temperature increased—Losartan—hypertension	5.53e-05	8.9e-05	CcSEcCtD
Goserelin—Nausea—Verapamil—hypertension	5.52e-05	8.88e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—YWHAZ—hypertension	5.52e-05	0.00015	CbGpPWpGaD
Goserelin—Asthenia—Captopril—hypertension	5.51e-05	8.87e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—EDNRA—hypertension	5.51e-05	0.00015	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SST—hypertension	5.51e-05	0.00015	CbGpPWpGaD
Goserelin—Diarrhoea—Trandolapril—hypertension	5.51e-05	8.85e-05	CcSEcCtD
Goserelin—Vomiting—Valsartan—hypertension	5.5e-05	8.85e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CALM1—hypertension	5.49e-05	0.000149	CbGpPWpGaD
Goserelin—Confusional state—Lisinopril—hypertension	5.49e-05	8.83e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—FLT1—hypertension	5.49e-05	0.000149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CYBA—hypertension	5.49e-05	0.000149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB1—hypertension	5.49e-05	0.000149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DRD3—hypertension	5.49e-05	0.000149	CbGpPWpGaD
Goserelin—Diarrhoea—Enalapril—hypertension	5.48e-05	8.82e-05	CcSEcCtD
Goserelin—Hypotension—Timolol—hypertension	5.48e-05	8.82e-05	CcSEcCtD
Goserelin—Hypersensitivity—Irbesartan—hypertension	5.48e-05	8.81e-05	CcSEcCtD
Goserelin—Vomiting—Olmesartan—hypertension	5.48e-05	8.81e-05	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Ramipril—hypertension	5.47e-05	8.79e-05	CcSEcCtD
Goserelin—Rash—Valsartan—hypertension	5.46e-05	8.78e-05	CcSEcCtD
Goserelin—Dizziness—Clonidine—hypertension	5.46e-05	8.77e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NGF—hypertension	5.45e-05	0.000148	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPP1—hypertension	5.45e-05	0.000148	CbGpPWpGaD
Goserelin—Dermatitis—Valsartan—hypertension	5.45e-05	8.77e-05	CcSEcCtD
Goserelin—Oedema—Lisinopril—hypertension	5.44e-05	8.75e-05	CcSEcCtD
Goserelin—Anaphylactic shock—Lisinopril—hypertension	5.44e-05	8.75e-05	CcSEcCtD
Goserelin—Pruritus—Captopril—hypertension	5.44e-05	8.75e-05	CcSEcCtD
Goserelin—Hypersensitivity—Hydrochlorothiazide—hypertension	5.44e-05	8.74e-05	CcSEcCtD
Goserelin—Rash—Olmesartan—hypertension	5.43e-05	8.73e-05	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—hypertension	5.43e-05	0.000148	CbGpPWpGaD
Goserelin—Insomnia—Ramipril—hypertension	5.43e-05	8.73e-05	CcSEcCtD
Goserelin—Dermatitis—Olmesartan—hypertension	5.43e-05	8.73e-05	CcSEcCtD
Goserelin—Headache—Valsartan—hypertension	5.42e-05	8.72e-05	CcSEcCtD
Goserelin—Diarrhoea—Telmisartan—hypertension	5.41e-05	8.7e-05	CcSEcCtD
Goserelin—Infection—Lisinopril—hypertension	5.41e-05	8.7e-05	CcSEcCtD
Goserelin—Headache—Olmesartan—hypertension	5.4e-05	8.68e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRA2A—hypertension	5.39e-05	0.000147	CbGpPWpGaD
Goserelin—Paraesthesia—Ramipril—hypertension	5.39e-05	8.67e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PLAT—hypertension	5.37e-05	0.000146	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GHRL—hypertension	5.37e-05	0.000146	CbGpPWpGaD
Goserelin—Shock—Lisinopril—hypertension	5.36e-05	8.61e-05	CcSEcCtD
Goserelin—Asthenia—Perindopril—hypertension	5.35e-05	8.61e-05	CcSEcCtD
Goserelin—Dyspnoea—Ramipril—hypertension	5.35e-05	8.61e-05	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Timolol—hypertension	5.35e-05	8.6e-05	CcSEcCtD
Goserelin—Hypersensitivity—Furosemide—hypertension	5.35e-05	8.6e-05	CcSEcCtD
Goserelin—Asthenia—Irbesartan—hypertension	5.34e-05	8.58e-05	CcSEcCtD
Goserelin—Somnolence—Ramipril—hypertension	5.34e-05	8.58e-05	CcSEcCtD
Goserelin—Thrombocytopenia—Lisinopril—hypertension	5.33e-05	8.57e-05	CcSEcCtD
Goserelin—Dizziness—Trandolapril—hypertension	5.32e-05	8.56e-05	CcSEcCtD
Goserelin—Tachycardia—Lisinopril—hypertension	5.31e-05	8.54e-05	CcSEcCtD
Goserelin—Insomnia—Timolol—hypertension	5.31e-05	8.54e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PRKCD—hypertension	5.31e-05	0.000144	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR5—hypertension	5.31e-05	0.000144	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CALCA—hypertension	5.31e-05	0.000144	CbGpPWpGaD
Goserelin—Dizziness—Enalapril—hypertension	5.3e-05	8.52e-05	CcSEcCtD
Goserelin—Asthenia—Hydrochlorothiazide—hypertension	5.29e-05	8.51e-05	CcSEcCtD
Goserelin—Hypersensitivity—Betaxolol—hypertension	5.29e-05	8.51e-05	CcSEcCtD
Goserelin—Skin disorder—Lisinopril—hypertension	5.29e-05	8.5e-05	CcSEcCtD
Goserelin—Dyspepsia—Ramipril—hypertension	5.28e-05	8.5e-05	CcSEcCtD
Goserelin—Pruritus—Perindopril—hypertension	5.28e-05	8.49e-05	CcSEcCtD
Goserelin—Paraesthesia—Timolol—hypertension	5.27e-05	8.47e-05	CcSEcCtD
Goserelin—Pruritus—Irbesartan—hypertension	5.26e-05	8.46e-05	CcSEcCtD
Goserelin—Hyperhidrosis—Lisinopril—hypertension	5.26e-05	8.46e-05	CcSEcCtD
Goserelin—Diarrhoea—Captopril—hypertension	5.26e-05	8.46e-05	CcSEcCtD
Goserelin—Vomiting—Clonidine—hypertension	5.25e-05	8.44e-05	CcSEcCtD
Goserelin—Dyspnoea—Timolol—hypertension	5.23e-05	8.41e-05	CcSEcCtD
Goserelin—Dizziness—Telmisartan—hypertension	5.23e-05	8.41e-05	CcSEcCtD
Goserelin—Pruritus—Hydrochlorothiazide—hypertension	5.22e-05	8.39e-05	CcSEcCtD
Goserelin—Decreased appetite—Ramipril—hypertension	5.22e-05	8.39e-05	CcSEcCtD
Goserelin—Somnolence—Timolol—hypertension	5.22e-05	8.39e-05	CcSEcCtD
Goserelin—Asthenia—Furosemide—hypertension	5.21e-05	8.37e-05	CcSEcCtD
Goserelin—Rash—Clonidine—hypertension	5.2e-05	8.37e-05	CcSEcCtD
Goserelin—Dermatitis—Clonidine—hypertension	5.2e-05	8.36e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HTR2A—hypertension	5.19e-05	0.000141	CbGpPWpGaD
Goserelin—Anorexia—Lisinopril—hypertension	5.19e-05	8.34e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—C3—hypertension	5.19e-05	0.000141	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BDKRB2—hypertension	5.18e-05	0.000141	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—POMC—hypertension	5.18e-05	0.000141	CbGpPWpGaD
Goserelin—Fatigue—Ramipril—hypertension	5.17e-05	8.32e-05	CcSEcCtD
Goserelin—Headache—Clonidine—hypertension	5.17e-05	8.31e-05	CcSEcCtD
Goserelin—Dyspepsia—Timolol—hypertension	5.17e-05	8.31e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PRKCB—hypertension	5.16e-05	0.00014	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2—hypertension	5.16e-05	0.00014	CbGpPWpGaD
Goserelin—Hypersensitivity—Losartan—hypertension	5.16e-05	8.29e-05	CcSEcCtD
Goserelin—Asthenia—Betaxolol—hypertension	5.15e-05	8.29e-05	CcSEcCtD
Goserelin—Nausea—Valsartan—hypertension	5.14e-05	8.27e-05	CcSEcCtD
Goserelin—Pruritus—Furosemide—hypertension	5.13e-05	8.25e-05	CcSEcCtD
Goserelin—Constipation—Ramipril—hypertension	5.13e-05	8.25e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRBK1—hypertension	5.12e-05	0.000139	CbGpPWpGaD
Goserelin—Nausea—Olmesartan—hypertension	5.12e-05	8.23e-05	CcSEcCtD
Goserelin—Vomiting—Trandolapril—hypertension	5.12e-05	8.23e-05	CcSEcCtD
Goserelin—Diarrhoea—Perindopril—hypertension	5.11e-05	8.21e-05	CcSEcCtD
Goserelin—Decreased appetite—Timolol—hypertension	5.1e-05	8.2e-05	CcSEcCtD
Goserelin—Vomiting—Enalapril—hypertension	5.1e-05	8.19e-05	CcSEcCtD
Goserelin—Diarrhoea—Irbesartan—hypertension	5.09e-05	8.18e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CNR1—hypertension	5.09e-05	0.000138	CbGpPWpGaD
Goserelin—Hypotension—Lisinopril—hypertension	5.09e-05	8.18e-05	CcSEcCtD
Goserelin—Dizziness—Captopril—hypertension	5.08e-05	8.17e-05	CcSEcCtD
Goserelin—Pruritus—Betaxolol—hypertension	5.08e-05	8.17e-05	CcSEcCtD
Goserelin—Rash—Trandolapril—hypertension	5.07e-05	8.16e-05	CcSEcCtD
Goserelin—Dermatitis—Trandolapril—hypertension	5.07e-05	8.15e-05	CcSEcCtD
Goserelin—Fatigue—Timolol—hypertension	5.06e-05	8.14e-05	CcSEcCtD
Goserelin—Rash—Enalapril—hypertension	5.05e-05	8.13e-05	CcSEcCtD
Goserelin—Dermatitis—Enalapril—hypertension	5.05e-05	8.12e-05	CcSEcCtD
Goserelin—Diarrhoea—Hydrochlorothiazide—hypertension	5.05e-05	8.12e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PDGFB—hypertension	5.05e-05	0.000137	CbGpPWpGaD
Goserelin—Headache—Trandolapril—hypertension	5.04e-05	8.11e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CALM2—hypertension	5.03e-05	0.000137	CbGpPWpGaD
Goserelin—Vomiting—Telmisartan—hypertension	5.03e-05	8.08e-05	CcSEcCtD
Goserelin—Asthenia—Losartan—hypertension	5.02e-05	8.08e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FGFR1—hypertension	5.02e-05	0.000136	CbGpPWpGaD
Goserelin—Headache—Enalapril—hypertension	5.02e-05	8.07e-05	CcSEcCtD
Goserelin—Pain—Timolol—hypertension	5.02e-05	8.07e-05	CcSEcCtD
Goserelin—Rash—Telmisartan—hypertension	4.98e-05	8.02e-05	CcSEcCtD
Goserelin—Dermatitis—Telmisartan—hypertension	4.98e-05	8.01e-05	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—AKT2—hypertension	4.97e-05	0.000135	CbGpPWpGaD
Goserelin—Diarrhoea—Furosemide—hypertension	4.96e-05	7.98e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HTR7—hypertension	4.96e-05	0.000135	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DRD2—hypertension	4.96e-05	0.000135	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Lisinopril—hypertension	4.96e-05	7.98e-05	CcSEcCtD
Goserelin—Pruritus—Losartan—hypertension	4.95e-05	7.96e-05	CcSEcCtD
Goserelin—Headache—Telmisartan—hypertension	4.95e-05	7.96e-05	CcSEcCtD
Goserelin—Feeling abnormal—Ramipril—hypertension	4.95e-05	7.95e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HIF1A—hypertension	4.95e-05	0.000134	CbGpPWpGaD
Goserelin—Dizziness—Perindopril—hypertension	4.93e-05	7.94e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—AGT—hypertension	4.93e-05	0.000134	CbGpPWpGaD
Goserelin—Insomnia—Lisinopril—hypertension	4.92e-05	7.92e-05	CcSEcCtD
Goserelin—Dizziness—Irbesartan—hypertension	4.92e-05	7.91e-05	CcSEcCtD
Goserelin—Diarrhoea—Betaxolol—hypertension	4.91e-05	7.9e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GCG—hypertension	4.91e-05	0.000134	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTPN1—hypertension	4.91e-05	0.000134	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Ramipril—hypertension	4.91e-05	7.89e-05	CcSEcCtD
Goserelin—Nausea—Clonidine—hypertension	4.9e-05	7.88e-05	CcSEcCtD
Goserelin—Paraesthesia—Lisinopril—hypertension	4.89e-05	7.86e-05	CcSEcCtD
Goserelin—Vomiting—Captopril—hypertension	4.89e-05	7.86e-05	CcSEcCtD
Goserelin—Dizziness—Hydrochlorothiazide—hypertension	4.88e-05	7.85e-05	CcSEcCtD
Goserelin—Dyspnoea—Lisinopril—hypertension	4.85e-05	7.8e-05	CcSEcCtD
Goserelin—Rash—Captopril—hypertension	4.85e-05	7.79e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CALM1—hypertension	4.84e-05	0.000132	CbGpPWpGaD
Goserelin—Dermatitis—Captopril—hypertension	4.84e-05	7.79e-05	CcSEcCtD
Goserelin—Somnolence—Lisinopril—hypertension	4.84e-05	7.78e-05	CcSEcCtD
Goserelin—Feeling abnormal—Timolol—hypertension	4.84e-05	7.78e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOE—hypertension	4.83e-05	0.000131	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LEP—hypertension	4.83e-05	0.000131	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KL—hypertension	4.82e-05	0.000131	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH2—hypertension	4.82e-05	0.000131	CbGpPWpGaD
Goserelin—Headache—Captopril—hypertension	4.82e-05	7.74e-05	CcSEcCtD
Goserelin—Gastrointestinal pain—Timolol—hypertension	4.8e-05	7.72e-05	CcSEcCtD
Goserelin—Dizziness—Furosemide—hypertension	4.8e-05	7.72e-05	CcSEcCtD
Goserelin—Dyspepsia—Lisinopril—hypertension	4.79e-05	7.71e-05	CcSEcCtD
Goserelin—Diarrhoea—Losartan—hypertension	4.79e-05	7.7e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CAV1—hypertension	4.78e-05	0.00013	CbGpPWpGaD
Goserelin—Nausea—Trandolapril—hypertension	4.78e-05	7.69e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOA1—hypertension	4.77e-05	0.00013	CbGpPWpGaD
Goserelin—Urticaria—Ramipril—hypertension	4.77e-05	7.67e-05	CcSEcCtD
Goserelin—Nausea—Enalapril—hypertension	4.76e-05	7.66e-05	CcSEcCtD
Goserelin—Dizziness—Betaxolol—hypertension	4.75e-05	7.64e-05	CcSEcCtD
Goserelin—Vomiting—Perindopril—hypertension	4.74e-05	7.63e-05	CcSEcCtD
Goserelin—Abdominal pain—Ramipril—hypertension	4.74e-05	7.63e-05	CcSEcCtD
Goserelin—Body temperature increased—Ramipril—hypertension	4.74e-05	7.63e-05	CcSEcCtD
Goserelin—Decreased appetite—Lisinopril—hypertension	4.73e-05	7.61e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—KDR—hypertension	4.73e-05	0.000129	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NGFR—hypertension	4.73e-05	0.000129	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ITGAV—hypertension	4.73e-05	0.000129	CbGpPWpGaD
Goserelin—Vomiting—Irbesartan—hypertension	4.73e-05	7.61e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—KNG1—hypertension	4.72e-05	0.000128	CbGpPWpGaD
Goserelin—Rash—Perindopril—hypertension	4.71e-05	7.57e-05	CcSEcCtD
Goserelin—Dermatitis—Perindopril—hypertension	4.7e-05	7.56e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—POMC—hypertension	4.7e-05	0.000128	CbGpPWpGaD
Goserelin—Nausea—Telmisartan—hypertension	4.7e-05	7.55e-05	CcSEcCtD
Goserelin—Fatigue—Lisinopril—hypertension	4.69e-05	7.55e-05	CcSEcCtD
Goserelin—Vomiting—Hydrochlorothiazide—hypertension	4.69e-05	7.54e-05	CcSEcCtD
Goserelin—Rash—Irbesartan—hypertension	4.69e-05	7.54e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AGTR1—hypertension	4.69e-05	0.000127	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRL—hypertension	4.69e-05	0.000127	CbGpPWpGaD
Goserelin—Dermatitis—Irbesartan—hypertension	4.69e-05	7.54e-05	CcSEcCtD
Goserelin—Headache—Perindopril—hypertension	4.68e-05	7.52e-05	CcSEcCtD
Goserelin—Urticaria—Timolol—hypertension	4.66e-05	7.5e-05	CcSEcCtD
Goserelin—Headache—Irbesartan—hypertension	4.66e-05	7.49e-05	CcSEcCtD
Goserelin—Pain—Lisinopril—hypertension	4.65e-05	7.49e-05	CcSEcCtD
Goserelin—Constipation—Lisinopril—hypertension	4.65e-05	7.49e-05	CcSEcCtD
Goserelin—Rash—Hydrochlorothiazide—hypertension	4.65e-05	7.48e-05	CcSEcCtD
Goserelin—Dermatitis—Hydrochlorothiazide—hypertension	4.65e-05	7.47e-05	CcSEcCtD
Goserelin—Body temperature increased—Timolol—hypertension	4.64e-05	7.46e-05	CcSEcCtD
Goserelin—Abdominal pain—Timolol—hypertension	4.64e-05	7.46e-05	CcSEcCtD
Goserelin—Dizziness—Losartan—hypertension	4.63e-05	7.44e-05	CcSEcCtD
Goserelin—Headache—Hydrochlorothiazide—hypertension	4.62e-05	7.43e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—STK11—hypertension	4.62e-05	0.000126	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HDAC1—hypertension	4.62e-05	0.000126	CbGpPWpGaD
Goserelin—Vomiting—Furosemide—hypertension	4.61e-05	7.42e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCL2—hypertension	4.6e-05	0.000125	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL10—hypertension	4.58e-05	0.000125	CbGpPWpGaD
Goserelin—Rash—Furosemide—hypertension	4.57e-05	7.36e-05	CcSEcCtD
Goserelin—Dermatitis—Furosemide—hypertension	4.57e-05	7.35e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PLG—hypertension	4.57e-05	0.000124	CbGpPWpGaD
Goserelin—Vomiting—Betaxolol—hypertension	4.57e-05	7.34e-05	CcSEcCtD
Goserelin—Nausea—Captopril—hypertension	4.57e-05	7.34e-05	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—RHOA—hypertension	4.56e-05	0.000124	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—F2—hypertension	4.55e-05	0.000124	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCB—hypertension	4.55e-05	0.000124	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FN1—hypertension	4.55e-05	0.000124	CbGpPWpGaD
Goserelin—Headache—Furosemide—hypertension	4.54e-05	7.31e-05	CcSEcCtD
Goserelin—Rash—Betaxolol—hypertension	4.53e-05	7.28e-05	CcSEcCtD
Goserelin—Dermatitis—Betaxolol—hypertension	4.52e-05	7.28e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AKT2—hypertension	4.52e-05	0.000123	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3R1—hypertension	4.51e-05	0.000123	CbGpPWpGaD
Goserelin—Headache—Betaxolol—hypertension	4.5e-05	7.24e-05	CcSEcCtD
Goserelin—Feeling abnormal—Lisinopril—hypertension	4.49e-05	7.21e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NOTCH1—hypertension	4.46e-05	0.000121	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Lisinopril—hypertension	4.45e-05	7.16e-05	CcSEcCtD
Goserelin—Vomiting—Losartan—hypertension	4.45e-05	7.16e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRB2—hypertension	4.45e-05	0.000121	CbGpPWpGaD
Goserelin—Nausea—Perindopril—hypertension	4.43e-05	7.13e-05	CcSEcCtD
Goserelin—Hypersensitivity—Ramipril—hypertension	4.42e-05	7.11e-05	CcSEcCtD
Goserelin—Nausea—Irbesartan—hypertension	4.42e-05	7.11e-05	CcSEcCtD
Goserelin—Rash—Losartan—hypertension	4.41e-05	7.1e-05	CcSEcCtD
Goserelin—Dermatitis—Losartan—hypertension	4.41e-05	7.09e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PRKCE—hypertension	4.39e-05	0.000119	CbGpPWpGaD
Goserelin—Headache—Losartan—hypertension	4.39e-05	7.05e-05	CcSEcCtD
Goserelin—Nausea—Hydrochlorothiazide—hypertension	4.38e-05	7.05e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PDGFA—hypertension	4.34e-05	0.000118	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VAV3—hypertension	4.34e-05	0.000118	CbGpPWpGaD
Goserelin—Urticaria—Lisinopril—hypertension	4.32e-05	6.95e-05	CcSEcCtD
Goserelin—Hypersensitivity—Timolol—hypertension	4.32e-05	6.95e-05	CcSEcCtD
Goserelin—Nausea—Furosemide—hypertension	4.31e-05	6.93e-05	CcSEcCtD
Goserelin—Asthenia—Ramipril—hypertension	4.31e-05	6.93e-05	CcSEcCtD
Goserelin—Abdominal pain—Lisinopril—hypertension	4.3e-05	6.92e-05	CcSEcCtD
Goserelin—Body temperature increased—Lisinopril—hypertension	4.3e-05	6.92e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—TGFBR2—hypertension	4.27e-05	0.000116	CbGpPWpGaD
Goserelin—Nausea—Betaxolol—hypertension	4.27e-05	6.86e-05	CcSEcCtD
Goserelin—Pruritus—Ramipril—hypertension	4.25e-05	6.83e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GNB3—hypertension	4.23e-05	0.000115	CbGpPWpGaD
Goserelin—Asthenia—Timolol—hypertension	4.21e-05	6.77e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AVP—hypertension	4.18e-05	0.000114	CbGpPWpGaD
Goserelin—Nausea—Losartan—hypertension	4.16e-05	6.69e-05	CcSEcCtD
Goserelin—Pruritus—Timolol—hypertension	4.15e-05	6.68e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—POMC—hypertension	4.15e-05	0.000113	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RHOA—hypertension	4.14e-05	0.000113	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—INS—hypertension	4.12e-05	0.000112	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNAS—hypertension	4.12e-05	0.000112	CbGpPWpGaD
Goserelin—Diarrhoea—Ramipril—hypertension	4.11e-05	6.6e-05	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PIK3R1—hypertension	4.1e-05	0.000111	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL2—hypertension	4.06e-05	0.00011	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOB—hypertension	4.04e-05	0.00011	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTK2—hypertension	4.02e-05	0.000109	CbGpPWpGaD
Goserelin—Diarrhoea—Timolol—hypertension	4.01e-05	6.46e-05	CcSEcCtD
Goserelin—Hypersensitivity—Lisinopril—hypertension	4.01e-05	6.45e-05	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—hypertension	4e-05	0.000109	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—hypertension	3.99e-05	0.000108	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT2—hypertension	3.99e-05	0.000108	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDN1—hypertension	3.97e-05	0.000108	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—hypertension	3.97e-05	0.000108	CbGpPWpGaD
Goserelin—Dizziness—Ramipril—hypertension	3.97e-05	6.38e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCL5—hypertension	3.94e-05	0.000107	CbGpPWpGaD
Goserelin—Asthenia—Lisinopril—hypertension	3.91e-05	6.28e-05	CcSEcCtD
Goserelin—Dizziness—Timolol—hypertension	3.88e-05	6.24e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—LPL—hypertension	3.86e-05	0.000105	CbGpPWpGaD
Goserelin—Pruritus—Lisinopril—hypertension	3.85e-05	6.19e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—H2AFX—hypertension	3.83e-05	0.000104	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFRB—hypertension	3.82e-05	0.000104	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RPS6KB1—hypertension	3.82e-05	0.000104	CbGpPWpGaD
Goserelin—Vomiting—Ramipril—hypertension	3.82e-05	6.14e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—hypertension	3.79e-05	0.000103	CbGpPWpGaD
Goserelin—Rash—Ramipril—hypertension	3.78e-05	6.09e-05	CcSEcCtD
Goserelin—Dermatitis—Ramipril—hypertension	3.78e-05	6.08e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADCY5—hypertension	3.77e-05	0.000103	CbGpPWpGaD
Goserelin—Headache—Ramipril—hypertension	3.76e-05	6.05e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PRKCG—hypertension	3.75e-05	0.000102	CbGpPWpGaD
Goserelin—Vomiting—Timolol—hypertension	3.73e-05	6e-05	CcSEcCtD
Goserelin—Diarrhoea—Lisinopril—hypertension	3.72e-05	5.99e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ITGB3—hypertension	3.72e-05	0.000101	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCA—hypertension	3.72e-05	0.000101	CbGpPWpGaD
Goserelin—Rash—Timolol—hypertension	3.7e-05	5.95e-05	CcSEcCtD
Goserelin—Dermatitis—Timolol—hypertension	3.7e-05	5.94e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—YWHAZ—hypertension	3.69e-05	0.0001	CbGpPWpGaD
Goserelin—Headache—Timolol—hypertension	3.68e-05	5.91e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—FGF2—hypertension	3.67e-05	9.97e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RHOA—hypertension	3.65e-05	9.93e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NGF—hypertension	3.65e-05	9.93e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPP1—hypertension	3.65e-05	9.93e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—hypertension	3.64e-05	9.88e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3R1—hypertension	3.62e-05	9.83e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—hypertension	3.62e-05	9.83e-05	CbGpPWpGaD
Goserelin—Dizziness—Lisinopril—hypertension	3.6e-05	5.79e-05	CcSEcCtD
Goserelin—Nausea—Ramipril—hypertension	3.57e-05	5.73e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR5—hypertension	3.55e-05	9.66e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCD—hypertension	3.55e-05	9.66e-05	CbGpPWpGaD
Goserelin—Nausea—Timolol—hypertension	3.49e-05	5.61e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HTR2A—hypertension	3.48e-05	9.45e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—C3—hypertension	3.47e-05	9.44e-05	CbGpPWpGaD
Goserelin—Vomiting—Lisinopril—hypertension	3.46e-05	5.57e-05	CcSEcCtD
Goserelin—Rash—Lisinopril—hypertension	3.43e-05	5.52e-05	CcSEcCtD
Goserelin—Dermatitis—Lisinopril—hypertension	3.43e-05	5.51e-05	CcSEcCtD
Goserelin—Headache—Lisinopril—hypertension	3.41e-05	5.48e-05	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RELA—hypertension	3.4e-05	9.25e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFB—hypertension	3.38e-05	9.18e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGFR1—hypertension	3.36e-05	9.14e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MTOR—hypertension	3.34e-05	9.07e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIF1A—hypertension	3.31e-05	9e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGT—hypertension	3.3e-05	8.97e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CALM1—hypertension	3.24e-05	8.82e-05	CbGpPWpGaD
Goserelin—Nausea—Lisinopril—hypertension	3.23e-05	5.2e-05	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—LEP—hypertension	3.23e-05	8.79e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—hypertension	3.23e-05	8.79e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—hypertension	3.21e-05	8.72e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CAV1—hypertension	3.2e-05	8.7e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA1—hypertension	3.19e-05	8.68e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—hypertension	3.17e-05	8.61e-05	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—hypertension	3.1e-05	8.42e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—hypertension	3.05e-05	8.29e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2—hypertension	3.05e-05	8.28e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FN1—hypertension	3.05e-05	8.28e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCB—hypertension	3.05e-05	8.28e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH1—hypertension	2.98e-05	8.11e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—hypertension	2.9e-05	7.89e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1A—hypertension	2.89e-05	7.86e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTEN—hypertension	2.88e-05	7.84e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK8—hypertension	2.82e-05	7.67e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—hypertension	2.81e-05	7.65e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—POMC—hypertension	2.78e-05	7.55e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INS—hypertension	2.76e-05	7.5e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EP300—hypertension	2.75e-05	7.48e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—hypertension	2.72e-05	7.38e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SRC—hypertension	2.68e-05	7.27e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—hypertension	2.67e-05	7.26e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT2—hypertension	2.67e-05	7.25e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—hypertension	2.66e-05	7.22e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—hypertension	2.61e-05	7.08e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—hypertension	2.54e-05	6.89e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF2—hypertension	2.46e-05	6.67e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RHOA—hypertension	2.45e-05	6.65e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3R1—hypertension	2.42e-05	6.58e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—hypertension	2.42e-05	6.58e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—hypertension	2.4e-05	6.52e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—hypertension	2.39e-05	6.5e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—hypertension	2.34e-05	6.37e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RELA—hypertension	2.28e-05	6.19e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTOR—hypertension	2.23e-05	6.08e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—hypertension	2.15e-05	5.84e-05	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—hypertension	2.07e-05	5.64e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—hypertension	2.04e-05	5.55e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—hypertension	1.97e-05	5.35e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—hypertension	1.94e-05	5.28e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1A—hypertension	1.94e-05	5.26e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTEN—hypertension	1.93e-05	5.25e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK8—hypertension	1.89e-05	5.14e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—hypertension	1.88e-05	5.12e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EP300—hypertension	1.84e-05	5.01e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—hypertension	1.8e-05	4.9e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SRC—hypertension	1.79e-05	4.87e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—hypertension	1.74e-05	4.74e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—hypertension	1.66e-05	4.52e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—hypertension	1.6e-05	4.36e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—hypertension	1.6e-05	4.35e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—hypertension	1.57e-05	4.27e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—hypertension	1.32e-05	3.58e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—hypertension	1.21e-05	3.28e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—hypertension	1.11e-05	3.03e-05	CbGpPWpGaD
